A Master Thesis position (together with „Großpraktikum“, if required) starting mid-March/beginning April, is available at the Department of Pathobiochemistry of the Medical University of Vienna.
This call for applications is open to advanced students of a master's programme in (molecular) biology, pharmacy, biotechnology or a related discipline. Require-ments for a successful work are general curiosity for molecular mechanisms and a high degree of accuracy in lab work.
The project:
Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease and has emerged as a serious global health issue. Overnutrition and lack of exercise are considered to be the main causes. Lipid accumulation in the liver may result in oxidative stress and hepatic inflammation.
This project is aimed to gain new insights into anti- and pro-inflammatory signaling pathways depending on, but also contributing to the environment of
an inflamed fatty liver. A well-established human liver cell line will be used as a model and overnutrition will be simulated by feeding free fatty acids (palmitic and oleic acid). The effects of the novel gasotransmitter hydrogen sulfide will be investigated in this setting using the H2S donor GYY4137.
An allowance of € 460,-/month is available. For application (in German or English), send an e-mail with your CV and brief cover letter to:
hildegard.laggner@meduniwien.ac.at
a. o. Univ.-Prof.in Dr.in Hilde Laggner
Medizinische Universität Wien
Zentrum für Pathobiochemie und Genetik
Institut für Medizinische Chemie und Pathobiochemie
Währinger Straße 10, 1090 Wien, Austria
T: +43 (0)1 40160-38051
hildegard.laggner@meduniwien.ac.at
www.meduniwien.ac.at
|
